SEC FORM 4
$10,320,628.75
Roivant Sciences Ltd. (ROIV)
Sale of 284,707 shares at $36.25 per share.
Reporting Person Sukhatme Mayukh · Officer Title President & CIO · Transaction Code S
Traded Aug 17, 2026 · Disclosed Aug 18, 2026
Source: SEC Form 4 · 0001140361-26-033637 · filed 2026-08-18 · View filing →